Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling.

Lando M, Wilting SM, Snipstad K, Clancy T, Bierkens M, Aarnes EK, Holden M, Stokke T, Sundfør K, Holm R, Kristensen GB, Steenbergen RD, Lyng H.

J Pathol. 2013 May;230(1):59-69. doi: 10.1002/path.4168. Epub 2013 Mar 14.

PMID:
23335387
2.

Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.

Lyng H, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T.

BMC Genomics. 2006 Oct 20;7:268.

3.

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.

Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H.

Epigenetics. 2015;10(10):970-80. doi: 10.1080/15592294.2015.1085140.

4.

New approaches to pathogenic gene function discovery with human squamous cell cervical carcinoma by gene ontology.

Seo MJ, Bae SM, Kim YW, Kim YW, Hur SY, Ro DY, Lee JM, Namkoong SE, Kim CK, Ahn WS.

Gynecol Oncol. 2005 Mar;96(3):621-9.

PMID:
15721403
5.

Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas.

Herzog CR, Crist KA, Sabourin CL, Kelloff GJ, Boone CW, Stoner GD, You M.

Mol Carcinog. 2001 Mar;30(3):159-68.

PMID:
11301476
6.

RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.

Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ.

Lung Cancer. 2010 Dec;70(3):253-62. doi: 10.1016/j.lungcan.2010.02.012. Epub 2010 Mar 24.

PMID:
20338664
7.

Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.

Ng G, Winder D, Muralidhar B, Gooding E, Roberts I, Pett M, Mukherjee G, Huang J, Coleman N.

J Pathol. 2007 Jul;212(3):325-34.

PMID:
17516585
8.

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.

Connolly DC, Greenspan DL, Wu R, Ren X, Dunn RL, Shah KV, Jones RW, Bosch FX, Muñoz N, Cho KR.

Clin Cancer Res. 2000 Sep;6(9):3505-10.

9.

Laminin-5 gamma 2 chain expression in cervical intraepithelial neoplasia and invasive cervical carcinoma.

Noel JC, Fernandez-Aguilar S, Fayt I, Buxant F, Ansion MH, Simon P, Anaf V.

Acta Obstet Gynecol Scand. 2005 Nov;84(11):1119-23.

PMID:
16232183
10.
11.

Loss of estrogen receptor 1 enhances cervical cancer invasion.

Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER, Cho KR.

Am J Pathol. 2010 Aug;177(2):884-95. doi: 10.2353/ajpath.2010.091166. Epub 2010 Jun 25.

12.

Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.

Mitra S, Mazumder Indra D, Basu PS, Mondal RK, Roy A, Roychoudhury S, Panda CK.

Mol Carcinog. 2012 Sep;51(9):723-33. doi: 10.1002/mc.20837. Epub 2011 Aug 1.

PMID:
21809394
13.

Deletion of chromosome 3p is an early event in malignant progression of cervical cancer.

Guo Z, Wilander E, Sällström J, Pontén J.

Anticancer Res. 1998 Mar-Apr;18(2A):707-12.

PMID:
9615709
14.

Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma.

Sheu JJ, Lee CH, Ko JY, Tsao GS, Wu CC, Fang CY, Tsai FJ, Hua CH, Chen CL, Chen JY.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2709-16. doi: 10.1158/1055-9965.EPI-09-0349.

15.

Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.

Yeasmin S, Nakayama K, Ishibashi M, Katagiri A, Iida K, Purwana IN, Nakayama N, Miyazaki K.

Clin Cancer Res. 2008 Mar 15;14(6):1686-91. doi: 10.1158/1078-0432.CCR-07-4085.

16.

Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma.

Guo Z, Wu F, Asplund A, Hu X, Mazurenko N, Kisseljov F, Pontén J, Wilander E.

Mod Pathol. 2001 Feb;14(2):54-61.

17.

3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.

Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ.

Cancer Res. 2006 Apr 1;66(7):3419-27.

18.

An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesis.

Backsch C, Rudolph B, Steinbach D, Scheungraber C, Liesenfeld M, Häfner N, Hildner M, Habenicht A, Runnebaum IB, Dürst M.

Carcinogenesis. 2011 Jul;32(7):1100-6. doi: 10.1093/carcin/bgr093. Epub 2011 May 19.

PMID:
21602178
19.

Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.

Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.

Cancer Res. 1997 Nov 1;57(21):4692-8.

20.

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.

Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper MS, Jackson DG, Sleeman JP, Jacobs IJ.

J Pathol. 2003 Dec;201(4):544-54.

PMID:
14648657

Supplemental Content

Support Center